Interaksi Anastrozol
Anastrozol (Arimidex), golongan penghambat aromatase, memiliki 27 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 17 mayor, 0 moderat, 0 minor, dan 10 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.
Seperti apa tampilan Anastrozol
Semua 9 versiGambar hasil render dari daftar produk pada label FDA: warna, bentuk, ukuran, dan kode cetak. 9 versi terdokumentasi dari 15 pelabel.
Interaksi dari label
Interaksi mayor (17)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)
• Tamoxifen: Do not use in combination with ARIMIDEX. (label Anastrozol, Interaksi obat)
Tidak ada interaksi bermakna yang dilaporkan (10)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)
Periksa Anastrozol terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.
Buka di pemeriksaBukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.



